oxaprozin (Compound)

Synonyms:oxaprozin, 21256-18-8, Daypro, 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid, Alvo, 3-(4,5-Diphenyloxazol-2-yl)propanoic acid, Oxaprozinum, Oxaprozine, Deflam, 4,5-Diphenyl-2-oxazolepropanoic acid, 4,5-Diphenyl-2-oxazolepropionic acid, WY-21,743, Oxaprozine [INN-French], Oxaprozinum [INN-Latin], WY-21743, Oxaprozina [INN-Spanish], Oxaprozina, 2-Oxazolepropanoic acid, 4,5-diphenyl-, Duraprox, Oxaprozinum;Wy21743, WY 21743, MFCD00215977, NSC310839, NSC-310839, 3-(4,5-Diphenyl-2-oxazolyl)propenoic acid, 3-(diphenyl-1,3-oxazol-2-yl)propanoic acid, beta-(4,5-Diphenyloxazol-2-yl)propionic acid, MHJ80W9LRB, NSC 310839, CHEMBL1071, CHEBI:7822, DTXSID1045118, Voir, 2-OXAZOLEPROPIONIC ACID, 4,5-DIPHENYL-, .beta.-(4,5-Diphenyloxazol-2-yl)propionic acid, Wy21743, Danoprox, Dayrun, 3-(4,5-Diphenyl-2-oxazolyl)propanoic acid, CAS-21256-18-8, DTXCID9025118, Actirin, Xopane, SMR000058286, Daypro (TN), SR-01000076053, oxaprosin, Durapro, Duraprost, Oxaprozi, Oxapro, Walix, Oxaprozin, solid, Oxaprozin,(S), Oxaprozin- Bio-X, EINECS 244-296-1, NCI310839, 4, 5-Diphenyl-2-oxazolepropionic acid, BRN 1083168, OXAPROZIN [INN], OXAPROZIN [JAN], OXAPROZIN [MI], OXAPROZIN [HSDB], OXAPROZIN [USAN], Maybridge1_008800, Prestwick0_001060, Prestwick1_001060, Prestwick2_001060, Prestwick3_001060, Spectrum2_001696, Spectrum3_001078, Spectrum4_001231, UNII-MHJ80W9LRB, Lopac-O-9637, OXAPROZIN [VANDF], OXAPROZIN [MART.], O 9637, OXAPROZIN [USP-RS], OXAPROZIN [WHO-DD], SCHEMBL3286, NCIStruc1_000799, NCIStruc2_000787, BIDD:PXR0149, Lopac0_000944, Oprea1_509470, BSPBio_001020, BSPBio_002696, KBioGR_001722, MLS000759535, MLS001424072, BIDD:GT0438, SPECTRUM1505267, SPBio_001652, SPBio_002940, Oxaprozin (JP17/USP/INN), BPBio1_001122, GTPL7252, OXAPROZIN [ORANGE BOOK], HMS566H22, HSDB 7586, KBio3_001916, OXAPROZIN [USP MONOGRAPH], HMS1571C22, HMS1922P17, HMS2051L15, HMS2093O08, HMS2098C22, HMS3262N10, HMS3393L15, HMS3652H17, HMS3715C22, HMS3885L11, Pharmakon1600-01505267, AMY32551, BCP28431, HY-B0808, Tox21_110059, Tox21_500944, 2-Oxazolepropanoic acid,5-diphenyl-, 2-Oxazolepropionic acid,5-diphenyl-, BDBM50002861, CCG-36508, NCGC00014711, NSC758949, s4230, 4,5-diphenyloxazole-2-propanoic acid, 4,5-Diphenyloxazole-2-propionic acid, AKOS000206807, Oxaprozin [USAN:USP:INN:BAN:JAN], Tox21_110059_1, CS-7975, DB00991, KS-5196, LP00944, NC00214, NSC-758949, SDCCGSBI-0050918.P004, NCGC00014711-01, NCGC00014711-02, NCGC00014711-03, NCGC00014711-04, NCGC00014711-05, NCGC00014711-06, NCGC00014711-07, NCGC00014711-08, NCGC00014711-09, NCGC00014711-10, NCGC00014711-11, NCGC00014711-14, NCGC00014711-15, NCGC00094249-01, NCGC00094249-02, NCGC00094249-03, NCGC00094249-04, NCGC00094249-05, NCGC00094249-06, NCGC00094249-07, NCGC00261629-01, Oxaprozin 100 microg/mL in Acetonitrile, AC-26512, BO164184, NCI60_002681, SY050819, SBI-0050918.P002, 3-(4,5-Diphenyl-2-oxazolyl)propionic acid, AB00514024, EU-0100944, FT-0638104, O0377, SW197319-4, 3-(4, 5-Diphenyl-2-oxazolyl)propenoic acid, EN300-25629, 3-(4,5-Diphenyl-oxazol-2-yl)-propionic acid, C07356, D00463, AB00514024_08, AB00514024_09, A815225, 1-AMINOCYCLOBUTANE-CIS-1,3-DICARBOXYLICACID, J-013955, Q1749609, SR-01000076053-1, SR-01000076053-3, SR-01000076053-7, SR-01000076053-9, 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid #, BRD-K25394294-001-05-7, BRD-K25394294-001-08-1, Z212055564, Oxaprozin, United States Pharmacopeia (USP) Reference Standard, BJ6

Pubchem:PUBCHEM:4614

Id:b8d12bb8-adbf-50e0-8977-a3c6bbbc5e4a

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View oxaprozin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for oxaprozin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with oxaprozin.

Results found

Linked to

	Label	Description
	BRD-K25394294-001-08-1 Substance (Entity type)	A Substance
	oxaprozin (f9b9ca9b-9fb5-40b4-8bb7-967fe6a041ab) Collection (Entity type)	Metadatata for oxaprozin
	DCSTRUCT ID 02013 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02013; PubChem_CID:4614, FILE=drugcentral_drug_02013.json)
	oxaprozin negatively regulates ROBO1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oxaprozin positively regulates LSM5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oxaprozin indication Degenerative polyarthritis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-(1-Cyclohexylpiperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine in similarity relationship with oxaprozin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oxaprozin in similarity relationship with Pritelivir; N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oxaprozin positively regulates DNAJA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	oxaprozin negatively regulates KLF10 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K25394294-001-08-1

Substance (Entity type)

A Substance

oxaprozin (f9b9ca9b-9fb5-40b4-8bb7-967fe6a041ab)

Collection (Entity type)

Metadatata for oxaprozin

DCSTRUCT ID 02013

Collection (Entity type)

DrugPage Collection: (DrugCentralID:02013; PubChem_CID:4614, FILE=drugcentral_drug_02013.json)

oxaprozin negatively regulates ROBO1

Knowledge Graph Assertion (Entity type)